JeanPierre Coaquira Castro, MPH

Gilead Sciences, Inc., Foster City, CA, United States

Disclosure(s): Gilead Sciences, Inc.: employee and shareholder

Poster(s):

• (P-326) Barriers to Oral HIV Pre-Exposure Prophylaxis (PrEP) Perceived by Those Receiving an Initial Prescription: US Survey Analysis
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET